Qi Xia

Randomized Phase II Study of Erlotinib Combined With Bevacizumab Compared With Bevacizumab Alone in Metastatic Renal Cell Cancer

Ronald M. Bukowski, Fairooz F. Kabbinavar, Robert A. Figlin et al. · Journal of Clinical Oncology · 2007 · 312 citations · Full text

Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial

Uwe Platzbecker, Valeria Santini, Pierre Fenaux et al. · The Lancet · 2023 · 118 citations

Hematological Malignancy, Thrombosis, Erythropoiesis-stimulating Agents +9

Hypertrophic smooth muscle in the partially obstructed opossum esophagus

H. N. Tung, K. Schulze‐Delrieu, Siroos S. Shirazi et al. · Gastroenterology · 1991 · 43 citations

Axial Skeleton, Esophagus, Physiology +5

The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients.

Victor T. Chang, Qi Xia, Basil Kasimis · PubMed · 2005 · 38 citations

Appetite, Nutrition, Functional Assessment +14

Safety of Onartuzumab in Patients with Solid Tumors: Experience to Date from the Onartuzumab Clinical Trial Program

Roland Morley, Alison K. Cardenas, Peter G. Hawkins et al. · PLoS ONE · 2015 · 29 citations · Full text